In the News
ÃÛÌÒ´«Ã½ experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ¡®Category¡¯ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Early intervention in neurodegenerative diseases, such as Alzheimer¡¯s, offers the potential to slow or prevent disease progression, and increase success rates for clinical development.
-
This list ranks the world¡¯s 500 most sustainable companies based on their public commitment to and progress toward sustainability targets. ÃÛÌÒ´«Ã½ was one of nine Irish-based companies to make this global list, recognising the impact of our ÃÛÌÒ´«Ã½ Cares programme.
-
The patent cliff for biologic medicines presents an opportunity for developers of biosimilars, but historically there are challenges too. The landscape however is changing, supporting easier paths to market.
-
As part of Pharma Tech Outlook's Regulatory Strategy, The Maestro Q&A series, ÃÛÌÒ´«Ã½ answers a range of questions around regulatory in clinical trials, timing and other considerations.
-
Dr Andrew Garrett, Executive VP Scientific Operations, ÃÛÌÒ´«Ã½, comments on the UK government¡¯s announcement on boost to clinical trials.
-
In this JCS article, ÃÛÌÒ´«Ã½'s experts discuss the key changes in FDA draft guidance on Data Monitoring Committees as it relates to adaptive design trials, providing practical insights and strategies for advanced safety oversight in the modern clinical trial landscape.
-
Since Regulation (EU) 2021/2282 (HTAR) came into effect, HTDs need to plan for a Joint Clinical Assessment (JCA) in addition to submitting their CTD to the EMA or medical device technical file to their notified body. In this article, ÃÛÌÒ´«Ã½ discusses this new requirement, factors to consider and the benefits.
-
This article highlights how AI is already adding value across pharma beyond headline?grabbing drug discovery, with ÃÛÌÒ´«Ã½ leveraging its in?house and proprietary AI tools¡ªlike its One?Search site?selection system, resource forecasting, endpoint strategy analytics, and document management platforms¡ªto improve clinical trial efficiency and address enrollment challenges.
-
New research from Symphony Health, an ÃÛÌÒ´«Ã½ plc company, featured in The American Journal of Managed Care (AMJC), highlights ongoing challenges in patient access to GLP-1 therapies for weight loss.
-
In this article, ÃÛÌÒ´«Ã½ experts explore strategies to help sponsors navigate the evolving obesity research landscape, highlighting the use of adaptive designs, master protocols, and other innovative approaches.
